DraftKings Inc vs Inovio Pharmaceuticals Inc — how do they compare? DraftKings Inc trades at $25.28 (market cap $12.51B), while Inovio Pharmaceuticals Inc trades at $1.18 (market cap $95.85M). The key difference: DraftKings Inc is far larger — about 130.5× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| DKNG | INO | |
|---|---|---|
Market Cap | $12.51B | $95.85M |
Sector | Consumer Cyclical | Health |
52-Week High | $48.23 | $2.87 |
52-Week Low | $20.72 | $1.05 |
Enterprise Value | $13.43B | $66.86M |
Trailing returns across standard periods
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →